DALLAS, July 17, 2009 (GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring drug development company Keryx Biopharmaceuticals Inc. (Nasdaq:KERX). The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
The investment report on Keryx Biopharmaceuticals Inc. (Nasdaq:KERX) should be of particular interest to other drug manufacturers: Novartis AG (NYSE:NVS), AstraZeneca plc (NYSE:AZN), Abbott Laboratories (NYSE:ABT) and Merck & Co. Inc. (NYSE:MRK).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.